London, United Kingdom
London, United Kingdom

Time filter

Source Type

Patent
PolyTherics | Date: 2017-04-26

A conjugate of the general formula: (((D_(q)-Lk^(1))_(m)-P)_(p)-Lk^(2)-Lk^(3))_(n)-Ab(I)in which D represents a drug moiety;q represents an integer from 2 to 10;Lk^(1) represents a linker;m represents an integer from 1 to 10;P represents a z-valent group -P^(1)-NH- where z is from 2 to 11 and P^(1) is a polyethylene glycol group;p represents an integer from 1 to 10;Lk^(2) represents a bond or a y-valent linker where y is from 2 to 11 and which consists of from 1 to 9 aspartate and/or glutamate residues;Lk^(3) represents a linker of the general formula: -CO-Ph-X-Y-(II)in which Ph is an optionally substituted phenyl group; X represents a CO group or a CH.OH group; and Y represents a group of formula:_(1-4)alkylene or alkenylene group;Ab represents a binding protein or peptide capable of binding to a binding partner on a target, said binding protein being bonded to Lk^(3) via two sulfur atoms derived from a disulfide bond in the binding protein or peptide; andn represents an integer from 1 to s where s is the number of disulfide bonds present in the binding protein or peptide prior to conjugation to Lk^(3);the meanings of m, n, p, q, y and z being chosen such that the conjugate contains from 1 to 10 D groups.


Patent
PolyTherics | Date: 2013-10-11

Specific conjugates containing auristatins and a binding protein or peptide, and processes for making them, are described. The conjugates use specific linker technology which gives advantages over known antibody-drug conjugates. Also described are specific conjugates of drugs and a binding protein or peptide in which more than one copy of the drug is present.


Patent
PolyTherics | Date: 2016-04-04

The present invention concerns a conjugate of a domain I 2GP1 polypeptide with a water-soluble polymer, wherein the polymer is bound via two cysteine residues derived from a disulfide bridge in the domain I 2GP1 polypeptide.


Patent
PolyTherics | Date: 2014-07-28

Novel biologically active compounds of the general formula (I) in which one of X and X represents a polymer, and the other represents a hydrogen atom; each Q independently represents a linking group; W represents an electron-withdrawing moiety or a moiety preparable by reduction of an electron-withdrawing moiety; or, if X represents a polymer, X-Q-W together may represent an electron withdrawing group; and in addition, if X represents a polymer, X and electron withdrawing group W together with the interjacent atoms may form a ring; each of Z^(1 )and Z^(2 )independently represents a group derived from a biological molecule, each of which is linked to A and B via an amine group; or Z^(1 )and Z^(2 )together represent a single group derived from a biological molecule which is linked to A and B via two amine groups; A is a C_(1-5 )alkylene or alkenylene chain; and B is a bond or a C_(1-4 )alkylene or alkenylene chain; are formed by conjugating a suitable polymer to a suitable biologically active molecule via amine groups in said molecule, preferably via a disulphide bridge.


A compound of the general formula X-[Q-W(CHCH)_(n)(CH_(2))_(2)-L]_(m )(I) in which X represents a polymer; Q represents a linking group; W represents an electron-withdrawing group; n represents 0 or an integer of from 1 to 4; L represents a leaving group; and m represent an integer of from 1 to 8. The compounds find use in the conjugation of biological molecules.


Patent
PolyTherics | Date: 2015-03-16

Novel compounds of the general formula: in which X represents a polymer, Q represents a linking group;W represents an electron-withdrawing moiety or a moiety preparable by reduction of an electron-withdrawing moiety;each of R^(1 )and R^(2 )independently represents a hydrogen atom or a C_(1-4)alkyl group; andeither Z^(1 )represents a protein or a peptide linked to CR^(2 )via a nucleophilic moiety, and Z^(2 )represents a molecule linked to CR^(2 )via a nucleophilic moiety, or Z^(1 )and Z^(2 )together represent a single group derived from a protein or peptide linked to CR^(2 )via two nucleophilic moieties.


Patent
PolyTherics | Date: 2013-10-11

Specific conjugates containing maytansines and a binding protein or peptide, and processes for making them, are described. The conjugates use specific linker technology which gives advantages over known antibody-drug conjugates.


The present invention concerns a process for the preparation of an antibody conjugate comprising the step of reacting an engineered antibody having a single inter-heavy chain disulfide bond with a conjugating reagent that forms a bridge between the two cysteine residues derived from the disulfide bond.


A compound of the general formula X[NRCOArCO(CHCH)_(n)(CH_(2))_(2)-L]_(m )(I) in which X represents a polymer; R represents a hydrogen atom or an alkyl, aryl or alkyl-aryl group; Ar represents an unsubstituted or substituted heteroaryl or aryl group; n represents 0 or an integer of from 1 to 4; L represents a leaving group; and m represents an integer of from 1 to 8. The compounds find use in the conjugation of biological molecules.


Patent
PolyTherics | Date: 2013-06-17

The invention provides compound of the general formula: in which each X independently represents a polymer chain; n represents an integer greater than 1; Q represents a linker; Y represents an amide group; and Z represents either CH.(CH_(2)L)_(2 )or C(CH_(2)L)(CH_(2)), in which each L independently represents a leaving group. The compounds are useful reagents for the conjugation of polymers to proteins, the resulting conjugates being novel and also forming part of the invention.

Loading PolyTherics collaborators
Loading PolyTherics collaborators